• Demographic and socioeconomic characteristics associated with SARS-CoV-2 reinfection:
  An observational study 11.03.2026

• Glucocorticoids suppress early lung inflammation and impair control of SARS-CoV-2 in non-human primates 11.03.2026

• Beyond Variant Evolution:
  Structurally and Functionally Conserved Regions in the 5′UTR of SARS-CoV-2 as Resilient Antiviral Targets 11.03.2026

• Personal household air pollution exposure and SARS-CoV-2 antibody responses among women and infants:
  an analysis within the HAPIN trial 11.03.2026

• Establishment and Evaluation of Human iPS Cell‐Derived Myeloid Cell Lines Susceptible to SARS‐CoV‐2 11.03.2026

• Effect of PEI25k/DOTAP/cholesterol liposomal formulation on the immunogenicity of SARS-CoV-2 spike protein-encoding DNA vaccine 11.03.2026

• A Case of Unilateral Choroidal Effusion with Secondary Angle-Closure Due to Severe Panuveitis After Anti-SARS-CoV-2 Vaccination 11.03.2026

• Early Placental Angioactive Response to Maternal SARS-CoV-2 Infection:
  an Immunohistochemical Study 11.03.2026

• Analytical and clinical evaluation of the Alinity m Resp-4-Plex assay in comparison to two singleplex SARS-CoV-2 assays and one multiplex respiratory assay 11.03.2026

• Erratum to “Antibody concentration and function following SARS-CoV-2 vaccination decrease with age in adults and children with down syndrome” [Vaccine 73 (2026) 128079] 11.03.2026

• Measurement of binding antibodies to SARS-CoV-2 variants elicited by natural infection and COVID-19 vaccines in a sub-Saharan African population 11.03.2026

• Converging Pathomechanisms Link SARS-CoV-2 Infection With Major Neurodegenerative Diseases 11.03.2026

• Ultra-sensitive detection of receptor binding domain of SARS-CoV-2 based on artificial intelligence assisted antibody selection and antibody‒nucleic acid conjugation signal amplification 11.03.2026

• Influence of Natural and/or Vaccine Immunity on the Dynamics of SARS-CoV-2 11.03.2026

• Targeting the RNA-binding Site of SARS-CoV-2 NSP13 by FRASE-bot in CACHE Challenge #2 11.03.2026

• Before status epilepticus in epilepsy patients is attributed to the SARS-CoV-2 vaccination, alternative causes must be ruled out 11.03.2026

• Infection, Reinfection and Post-Vaccination Infection of Sars-Cov-2 in Healthcare Workers at Alsader Teaching  Hospital in Maysan Province, Southern Iraq 11.03.2026

• Immunization with MVA-based vaccines protects K18-hACE2 mice from SARS-CoV-2 infection-associated inflammatory lesions in brains 11.03.2026

• The role of large immune complexes in anti-drug antibody development:
  a case study of anti-SARS-CoV-2 antibody therapeutics and co-administered mRNA vaccine 11.03.2026

• Spike Gene Target Failure Among RT-PCR Positive SARS-CoV-2 Samples in Dhaka City During Early Variant Waves 11.03.2026

• Rural targeted messaging, multiplex salivary measurement, and rural equity in SARS-CoV-2 antibody testing:
  Protocol overview of a SeroNet investigation 11.03.2026

• Pneumonia due to respiratory syncytial virus does not cause long-lasting disorders in respiratory gas transport after clinical resolution in adults. Comparison <i>vs</i>. SARS-CoV-2 pneumonia 11.03.2026

• Ancestral Wuhan SARS-CoV-2 anti-spike CD4+ T cells predict protection from symptomatic omicron breakthrough infection 11.03.2026

• Ownership change in American nursing homes during the COVID-19 pandemic and the relationship with measures in donabedian's model of care quality. 10.03.2026

• The promises and challenges of neoantigen cancer vaccines. 10.03.2026

• Bimekizumab longer-term safety profile in adult patients with axial spondyloarthritis or psoriatic arthritis:
  an updated analysis of six phase IIb/III clinical studies. 10.03.2026

• Exploring teamwork in fluid multiteam systems (MTS):
  a qualitative analysis of team effectiveness in public health emergent response teams in Wales, UK. 10.03.2026

• Establishment and Evaluation of Human iPS Cell-Derived Myeloid Cell Lines Susceptible to SARS-CoV-2. 10.03.2026

• Early Placental Angioactive Response to Maternal SARS-CoV-2 Infection:
  an Immunohistochemical Study. 10.03.2026

• Demographic and socioeconomic characteristics associated with SARS-CoV-2 reinfection:
  An observational study. 10.03.2026

• Glucocorticoids suppress early lung inflammation and impair control of SARS-CoV-2 in non-human primates. 10.03.2026

• Evaluating the role and clinical impact of extended respiratory viral PCR testing in adult inpatients. 10.03.2026

• Tolerating the turn:
  can an alternative pillow solution offer improved pressure redistribution during prone positioning? 10.03.2026

• Analytical and clinical evaluation of the Alinity m Resp-4-Plex assay in comparison to two singleplex SARS-CoV-2 assays and one multiplex respiratory assay. 10.03.2026

• Vitamin D and Zinc in SARS-CoV-2 Infection:
  Immunomodulatory Mechanisms and Clinical Evidence. 10.03.2026

• Depressive Symptoms in Patients With SARS-CoV-2 and Acute Coronary Syndrome 10.03.2026

• Comparison of immunogenicity and efficacy of mRNA and protein subunit SARS-CoV-2 vaccines in dialysis patients:
  a multicenter study 10.03.2026

• Computational Study of Antibody Binding to SARS-CoV-2 Variants 10.03.2026

• Serological profile of naïve patients affected by the first sars-cov-2 variant:
  A prospective study 10.03.2026

• Modelling approaches for estimating vaccine effectiveness of consecutive SARS-CoV-2 variant sublineages in the absence of study-specific genetic sequencing data, VEBIS hospital network, Europe, 2023/24 10.03.2026

• Retraction:
  Application of in-silico drug discovery techniques to discover a novel hit for target-specific inhibition of SARS-CoV-2 Mpro’s revealed allosteric binding with MAO-B receptor:
  A theoretical study to find a cure for post-covid neurological disorder 10.03.2026

• Proteomic insights into troponin elevation following COVID-19 infection 10.03.2026

• The Effect of SARS-CoV-2 on Bacterial Diversity and Abundance in Community Wastewater 10.03.2026

• Non-clinical analysis of virus-like particles (VLP) containing SARS-CoV-2 vaccine antigens 10.03.2026

• Erratum for Yuan et al., “Case-control and genomic epidemiology characterization of SARS-CoV-2 breakthrough infections during Delta-to-Omicron transition” 10.03.2026

• Infection-acquired protection against SARS-CoV-2 infection and clinical severity by number of prior infections 10.03.2026

• Ancestral Wuhan SARS-CoV-2 anti-spike CD4(+) T cells predict protection from symptomatic omicron breakthrough infection. 09.03.2026

• Non-clinical analysis of virus-like particles (VLP) containing SARS-CoV-2 vaccine antigens. 09.03.2026

• Pneumonia due to respiratory syncytial virus does not cause long-lasting disorders in respiratory gas transport after clinical resolution in adults. Comparison vs. SARS-CoV-2 pneumonia. 09.03.2026

• IFN-gene signatures in B cells following influenza A and B virus infection and influenza vaccination. 09.03.2026

• Glycan-binding properties of SARS-CoV-2 spike proteins:
  interactions with aminoglycoside antibiotics. 09.03.2026

• Amphotericin B promotes respiratory viral entry by enhancing late endosomal maturation and fusion via glucocerebrosidase-mediated ceramide remodeling. 09.03.2026

• Infection-acquired protection against SARS-CoV-2 infection and clinical severity by number of prior infections. 09.03.2026

• CoMBCR:
  Co-Learning Multi-Modalities of BCRs and Gene Expressions. 09.03.2026

• Glycan-binding properties of SARS-CoV-2 spike proteins:
  interactions with aminoglycoside antibiotics 09.03.2026

• SARS-CoV-2 Spike Protein Sensing Using Photonic Crystal Fiber Technology 09.03.2026

• Multi-Epitope DNA-Based Vaccine Targeting Nucleocapsid Protein of SARS-CoV-2:
  Immunoinformatic Design and In Vivo Validation 09.03.2026

• Impact of omicron variant SARS-CoV-2 on tumor suppressor P53 gene expression and interferon-alpha downregulation during early infection 09.03.2026

• Genomic Epidemiology of SARS-CoV-2 variants in unvaccinated children found to be similar to that of adults with COVID-19 vaccinations 09.03.2026

• Dermatomyositis with Anti-MDA5 Autoantibodies After SARS-CoV-2 mRNA Vaccination Treated with Tofacitinib:
  Integrating Literature Evidence and a Novel Observation 09.03.2026

• Ugi multicomponent reactions of optically active aldehydes and chiral aminoindanols:
  diastereoselective synthesis of bisamides relevant to SARS-CoV-2 Mpro inhibitors 09.03.2026

• Enhancing the Outcome of Crystallographic Fragment Screening by Choosing the Optimal Protein Crystal Form. 04.03.2026

• Will animal reservoirs give us the next SARS-CoV-2 variant? 03.03.2026

• Spike destabilization attenuates Mink Cluster 5 SARS-CoV-2. 03.03.2026

• COVID-19 vaccination and mortality among coronary care patients with severe acute respiratory infection in Bangladesh:
  a prospective study (2021-2024). 02.03.2026

• Viruses (Including SARS-CoV-2), Nematodes and Their Spread 02.03.2026

• Presentation and temporal nature of postacute sequelae of SARS-CoV-2 infection in a US national cohort. 27.02.2026

• The age paradox in post-infectious sequelae:
  physiological reserve outweighs chronological age in Long COVID susceptibility. 26.02.2026

• Novel antiviral compounds:
  Synthesis, biological studies on SARS-CoV-2, and structure-activity relationship analysis. 26.02.2026

• A narrative review of SARS-CoV-2 variants and long COVID 25.02.2026

• Welding fumes and SARS-CoV-2:
  a dangerous combination. 25.02.2026

• Preemptive rapid antigen test as an emergency measure during coronavirus disease 2019 outbreaks. 23.02.2026

• Harnessing SARS-CoV-2 immunity to promote antitumor responses through intratumoral vaccination and adoptive transfer. 23.02.2026

• Plasma proteomic profile reveals persistent immune activation in post-acute sequelae of SARS-CoV-2 infection. 23.02.2026

• Impact of Smoking on Household SARS-CoV-2 Transmission. 22.02.2026

• Screening of wild roe deer populations in Sweden 2016-2022 for SARS-CoV-2. 19.02.2026

• Factors predicting the outcome of patients admitted with COVID-19 infection at Pietersburg Hospital, Polokwane, Limpopo province. 18.02.2026

• Successful Treatment of Multiple Myeloma Complicated With SARS-CoV-2 Infection:
  A Case Report. 18.02.2026

• Impact of SARS-CoV-2 on Dental Practice:
  A Comprehensive Narrative Review 18.02.2026

• Lymphopenia in Bacterial Sepsis and SARS-CoV-2 Infection. 15.02.2026

• Challenges and Prospects in the Development of a Universal SARS-CoV-2 Vaccine. 13.02.2026

• The role of receptor binding and immunity in SARS-CoV-2 fitness landscape:
  A modeling study. 10.02.2026

• Depressive Symptoms in Patients With SARS-CoV-2 and Acute Coronary Syndrome. 07.02.2026

• Long-Term Olfactory Dysfunction in COVID-19 Patients:
  A Systematic Review. 07.02.2026

• Host Glycan-Lectin Interplay in SARS-CoV-2 Infection. 06.02.2026

• SARS-CoV-2 Infection and Vaccination, Immune Dysregulation, and Cancer 03.02.2026

• Impact of Smoking on Household SARS-CoV-2 Transmission 01.02.2026

• Therapeutic Approaches to Treat SARS-CoV-2. 01.02.2026

• Lymphopenia in Bacterial Sepsis and SARS-CoV-2 Infection 01.02.2026

• Genetic and Structural Analyses of Coronaviruses:
  Insights into SARS-CoV-2 and Beyond 01.02.2026

• A Systematic Review of Methodological Approaches to SARS-CoV-2 Wastewater Surveillance 01.02.2026

• SARS-CoV-2 Chronic Intervillositis:
  Variations of Maternal Antiviral Response. 01.02.2026

• SARS-CoV-2 vaccination and myositis in Norway and Sweden. 01.02.2026

• Tracing SARS-CoV-2 Evolution in Algeria:
  Insights from 2020 to 2023 01.02.2026

• Surveillance of Acute Respiratory Infections in Central India (2024-2025) Using Multiplex RT-PCR. 30.01.2026

• Molecular Characterization of Persistent SARS-CoV-2 Infections in Immunocompromised Patients 30.01.2026

• Influenza-Infected Pigs Are Not Susceptible to SARS-CoV-2 Infection 26.01.2026

• Influenza-Infected Pigs Are Not Susceptible to SARS-CoV-2 Infection. 26.01.2026

• Structural mimics of SARS-CoV-2. 22.01.2026

• CACHE Challenge #3:
  Targeting the Nsp3 Macrodomain of SARS-CoV-2. 21.01.2026

Quellen: PubMed, Europe PMC & CrossRef